BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  VBI Vaccines Strengthens Board of Directors With Appointment of Ran Nussbaum

  “We are honored to have Ran join our Board of Directors,” said Jeff Baxter, VBI’s president and CEO.

  November 2, 2017

   · 

  5 min read
• Business

  Evogene Financial Results for the Third Quarter of 2017 Earnings Announcement Schedule

  On the day of the announcement, the Company’s management will host a conference call to discuss the results at 09:00 AM ET.

  November 2, 2017

   · 

  2 min read
• Tigenix Strengthens European IP Protection Around Lead Development Program Cx601

  The use of Cx601 in treating fistulas is protected by European patent EP 2292737 entitled “Use of adipose tissue-derived stromal stem cells in treating fistula”.

  November 2, 2017

   · 

  6 min read
• Business

  AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights

  Total GAAP revenue for the third quarter of 2017 increased to $153.7 million, 7% higher than the same period last year.

  November 2, 2017

   · 

  30 min read
• Biotech Beach

  Human Factors Research Presented at DTM 2017 Demonstrates Ease of Use and Effectiveness of Computer-Based Training for Touchscreen Insulin Pump With Automated Insulin Delivery Feature

  The study demonstrated a 99 percent success rate among study participants who performed a series of critical tasks using the PLGS system after initial training.

  November 2, 2017

   · 

  4 min read
• Business

  Evonik and Lilly Renew Long-Term Supply Agreement

  Evonik Industries and Eli Lilly and Company (Lilly) today announced the renewal of a long-term agreement under which Evonik will supply active pharmaceutical ingredients (APIs) and intermediates for use in key Lilly human and veterinary drug products.

  November 2, 2017

   · 

  3 min read
• Business

  IntelGenx to Report Third Quarter 2017 Financial Results on November 9, 2017 - Conference Call to Follow

  An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer, and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update.

  November 2, 2017

   · 

  1 min read
• MTPConnect Opens Call For $5M Biomedtech Horizons Program, Supporting High-Potential Health Breakthroughs

  The BioMedTech Horizons program will provide $5M in 2017-18 to help Australia move more cutting-edge ideas and breakthrough discoveries towards proof-of-concept and commercialisation.

  November 2, 2017

   · 

  3 min read
• Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) With Boehringer Ingelheim Venture Fund

  BIVF will provide Topas with EUR 4 million (USD 5 million) to accelerate the Company’s preparation and execution of clinical trials for autoimmune programs derived from its platform.

  November 2, 2017

   · 

  3 min read
• MorphoSys Announces Presentation of Clinical Data on Proprietary Blood Cancer Compound MOR208 at Upcoming ASH Annual Meeting 2017

  MorphoSys announced the upcoming presentation of data on the Company’s proprietary investigational hemato-oncological program MOR208 at the 59th American Society of Hematology (ASH) Annual Meeting, being held December 9-12, 2017 in Atlanta, Georgia/USA.

  November 2, 2017

   · 

  4 min read